Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
Journal of psychopharmacology (Oxford, England) September 1, 2019 James D Sexton, Michael S Crawford, Noah W Sweat et al. 33 citations
Novel psychedelics, such as 2C-B, 2C-I, and 2C-E, are used by a very small fraction of the U.S. adult population (0.12%). Users tend to be younger, male, White, more educated but with lower income, and almost all have also used classic psychedelics. Compared to those who have used only classic psychedelics, people who have used novel psychedelics are more likely to report past-year suicidal thinking and planning, though novel psychedelic use alone is not associated with psychological distress or suicidality. The findings suggest novel psychedelics may differ from classic psychedelics in their mental health associations, but more research is needed.